Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?

Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study

(2012) Dimitrios Thomas et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms

(2012) Gianfranco Delle Fave et al.   NEUROENDOCRINOLOGY

Autoantibodies to parietal cells as predictors of atrophic body gastritis: A five-year prospective study in patients with autoimmune thyroid diseases

(2010) Renato Tozzoli et al.   AUTOIMMUNITY REVIEWS

Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters

(2010) Martin B Niederle et al.   ENDOCRINE-RELATED CANCER

Prevalence of Parietal Cell Antibodies in a Large Cohort of Patients with Autoimmune Thyroiditis

(2010) Serenella Checchi et al.   THYROID

Reassessment of Intrinsic Factor and Parietal Cell Autoantibodies in Atrophic Gastritis With Respect to Cobalamin Deficiency

(2009) Edith Lahner et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

l-Thyroxine Requirement in Patients with Autoimmune Hypothyroidism and Parietal Cell Antibodies

(2007) Serenella Checchi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM